Literature DB >> 15126802

Racial differences in prostate androgen levels in men with clinically localized prostate cancer.

James L Mohler1, Kris E Gaston, Dominic T Moore, Michael J Schell, Brian L Cohen, Catharina Weaver, Peter Petrusz.   

Abstract

PURPOSE: We sought to determine whether there are racial differences in androgenic stimulation within the prostate tissue microenvironment.
MATERIALS AND METHODS: Steroid hormones were extracted from snap frozen tissue obtained intraoperatively from radical prostatectomy specimens of 36 black and 59 white Americans. Testosterone, dihydrotestosterone (DHT), androstenedione (ASD), dehydroepiandrosterone, dehydroepiandrosterone sulfate, sex hormone-binding globulin (SHBG) and prostate specific antigen (PSA) were measured using radioimmunoassay. The Wilcoxon 2 group test was performed to compare clinical characteristics and tissue steroid levels between white and black Americans. Nonparametric rank ANOVA was used to consider race and other clinical factors in a multivariable way.
RESULTS: Black and white American men were similar with respect to serum PSA, and pathological grade and stage. However, black men were younger (p = 0.01) and had a significantly higher body mass index (p = 0.02). Black and white men had similar testosterone and DHT. However, black men had higher ASD (p = 0.006) and SHBG (p = 0.009). Racial differences in ASD (p = 0.015) and SHBG (p = 0.008) persisted after controlling for age, body mass index, PSA, and pathological Gleason sum and stage.
CONCLUSIONS: Tissue levels of testosterone and DHT did not differ by race. However, black men had higher tissue ASD and SHBG than white men. Higher tissue ASD did not result in a greater conversion of ASD to testosterone in the prostate of black men. Higher tissue SHBG may activate the androgen receptor through cyclic adenosine monophosphate dependent pathways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126802     DOI: 10.1097/01.ju.0000127739.88383.79

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  Adrenal androgens rescue prostatic dihydrotestosterone production and growth of prostate cancer cells after castration.

Authors:  Yue Wu; Li Tang; Gissou Azabdaftari; Elena Pop; Gary J Smith
Journal:  Mol Cell Endocrinol       Date:  2019-02-23       Impact factor: 4.102

2.  Androgenic biomarker prof|ling in human matrices and cell culture samples using high throughput, electrospray tandem mass spectrometry.

Authors:  John H Wilton; Mark A Titus; Eleni Efstathiou; Gerald J Fetterly; James L Mohler
Journal:  Prostate       Date:  2014-05       Impact factor: 4.104

3.  Characterization of Prostate Cancer in a Functional Eunuch.

Authors:  John J Stocking; Michael V Fiandalo; Elena A Pop; John H Wilton; Gissou Azabdaftari; James L Mohler
Journal:  J Natl Compr Canc Netw       Date:  2016-09       Impact factor: 11.908

4.  Prostate Cancer: Community Education and Disparities in Diagnosis and Treatment.

Authors:  Bradley Carthon; Hannah C Sibold; Shannon Blee; Rebecca D Pentz
Journal:  Oncologist       Date:  2021-03-22

Review 5.  Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.

Authors:  Tiffany A Wallace; Damali N Martin; Stefan Ambs
Journal:  Carcinogenesis       Date:  2011-04-03       Impact factor: 4.944

6.  Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Authors:  Jie Li; Emma Mercer; Xin Gou; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

Review 7.  Stromal androgen receptor in prostate development and cancer.

Authors:  Mandeep Singh; Ruchi Jha; Jonathan Melamed; Ellen Shapiro; Simon W Hayward; Peng Lee
Journal:  Am J Pathol       Date:  2014-08-01       Impact factor: 4.307

8.  Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men.

Authors:  Andre B Araujo; Thomas G Travison; Benjamin Z Leder; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2008-03-25       Impact factor: 5.958

Review 9.  Prostate tissue androgens: history and current clinical relevance.

Authors:  Leonard S Marks; Elahe A Mostaghel; Peter S Nelson
Journal:  Urology       Date:  2008-05-27       Impact factor: 2.649

10.  Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer.

Authors:  James L Gulley; Jeanny B Aragon-Ching; Seth M Steinberg; Maha H Hussain; Oliver Sartor; Celestia S Higano; Daniel P Petrylak; Gurkamal S Chatta; Philip M Arlen; William D Figg; William L Dahut
Journal:  J Urol       Date:  2008-08-16       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.